The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Some stimulatory receptors of the innate immune system, such as the NKG2D receptor (also called KLRK1) expressed by natural killer cells and activated CD8(+)T cells, recognize self-molecules that are upregulated in diseased cells by poorly understood mechanisms. Here we show that mouse and human NKG2D ligands are upregulated in non-tumour cell lines by genotoxic stress and stalled DNA replication, conditions known to activate a major DNA damage checkpoint pathway initiated by ATM (ataxia telangiectasia, mutated) or ATR (ATM- and Rad3-related) protein kinases. Ligand upregulation was prevented by pharmacological or genetic inhibition of ATR, ATM or Chk1 (a downstream transducer kinase in the pathway). Furthermore, constitutive ligand expression by a tumour cell line was inhibited by targeting short interfering RNA to ATM, suggesting that ligand expression in established tumour cells, which often harbour genomic irregularities, may be due to chronic activation of the DNA damage response pathway. Thus, the DNA damage response, previously shown to arrest the cell cycle and enhance DNA repair functions, or to trigger apoptosis, may also participate in alerting the immune system to the presence of potentially dangerous cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In addition, genomic damage—a common cause of cellular senescence—induces expression of the membrane-bound ligands for the major natural killer cell receptor NKG2D (140).”
From Aging, Cellular Senescence, and Cancer (2013) · cites this paper as [140]
The cited source says what the claim attributes to it.
In the citing paper
“other evidence indicates that the immune system's recognition of tumour cells might require the continuous activation of the DDR pathway 13”
From The common biology of cancer and ageing (2007) · cites this paper as [13]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Further, DNA damage or activation of oncogenes can induce cellular senescence, through a pathway that relies, in part, on the secretion of pro-inflammatory cytokines such as insulin-like growth factor binding protein-7 (IGFBP7)32 and IL-633, and on the secretion of CXC-chemokine ligand 8 (CXCL8) and other chemokines 33,34, as well as on the expression of the CXCL8 receptor CXC-chemokine receptor 2”
From Immunogenic and tolerogenic cell death (2009) · cites this paper as [32]
Experimental — accuracy not yet measuredIn the citing paper
“These findings are consistent with previous studies suggesting that NKG2D ligands are induced by a variety of other stimuli, including E2F transcription factors, PI3 kinase, Ras oncogene signaling, and an activated DNA damage response (Gasser et al., 2005; Tokuyama et al., 2011; Jung et al., 2012).”
From p53-dependent chemokine production by senescent tumor cells supports NKG2D-dependent tumor elimination by natural killer cells (2013) · cites this paper as Gasser et al., 2005
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: p73α Regulation by Chk1 in Response to DNA Damage
Gonzalez, S., Prives, C., & Cordon-Cardo, C. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.22.8161-8171.2003 · Cited by 75
RetractedDNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation
Bakkenist, C. J., & Kastan, M. B. (2003) · Nature · doi:10.1038/nature01368 · Cited by 3,466
Molecular Mechanisms of Mammalian DNA Repair and the DNA Damage Checkpoints
Sancar, A., Lindsey-Boltz, L. A., Ünsal-Kaçmaz, K., & Linn, S. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.011303.073723 · Cited by 3,317
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
Bartkova, J., Hořejší, Z., Koed, K., Krämer, A., Tort, F., Zieger, K., Guldberg, P., Sehested, M., Nesland, J. M., Lukas, C., et al. (2005) · Nature · doi:10.1038/nature03482 · Cited by 2,688
Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions
Gorgoulis, V. G., Vassiliou, L.-V. F., Karakaidos, P., Zacharatos, P., Kotsinas, A., Liloglou, T., Venere, M., DiTullio, R. A., Kastrinakis, N. G., Levy, B., et al. (2005) · Nature · doi:10.1038/nature03485 · Cited by 2,009
Cell cycle checkpoint signaling through the ATM and ATR kinases
Abraham, R. T. (2001) · Genes & Development · doi:10.1101/gad.914401 · Cited by 1,966
Chk1 and Chk2 kinases in checkpoint control and cancer
Bartek, J., & Lukas, J. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00110-7 · Cited by 1,513
Roles of the NKG2D immunoreceptor and its ligands
Raulet, D. H. (2003) · Nature Reviews Immunology · doi:10.1038/nri1199 · Cited by 1,348
Self-citation(1999) · PubMed · Cited by 1,030
ATR disruption leads to chromosomal fragmentation and early embryonic lethality
Brown, E. J., & Baltimore, D. (2000) · Genes & Development · doi:10.1101/gad.14.4.397 · Cited by 951
Self-citation
Cited by
Items 701–800 of 1,000
Wu, X., Chen, X., Liu, H., He, Z., Wang, Z., Wei, L.-J., Wang, W., Zhong, S., He, Q., Zhang, Z., et al. (2020) · Theranostics · doi:10.7150/thno.41894 · Cited by 29
“DNA damage can promote inflammation by inducing the expression of NKG2D ligands; upregulation of NKG2D ligands can initiate immune-mediated tissue damage and induce inflammation [22, 23].”
BackgroundQian, X., Yi, W., Yan, W., Cai, Y., Hu, S., Yan, D., Zhao, Z., Li, R. H., Wang, L., Xu, H., et al. (2025) · Advanced Materials · doi:10.1002/adma.202413289 · Cited by 30
Zajonc, D. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207561 · Cited by 29
“Especially, tumors that downregulate classical MHC I expression to evade TCR mediated recognition, or upregulate non-classical MHC I activating ligands (altered-self recognition) are ideal targets for NK cells [79,80].”
BackgroundDing, X., Cao, H., Chen, X., Jin, H., Liu, Z., Wang, G., Cai, L., Li, D., Niu, C. S., Tian, H., et al. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0514-0 · Cited by 28
“Besides, chemotherapy could not only alleviate immune suppression by reducing the tumor burden [32, 33], but also up-regulate the expression of the NKG2D ligands on cancer cells, thus sensitizing them to lysis mediated by NKG2D-expressing lymphocytes [34].”
BackgroundSTING-dependent cytosolic DNA sensor pathways regulate NKG2D ligand expression
Bert, N. L., Lam, A. R., Ho, S. S. W., Shen, Y. J., Liu, M., & Gasser, S. (2014) · OncoImmunology · doi:10.4161/onci.29259 · Cited by 28
Self-citationImmunological role and underlying mechanisms of B7‐H6 in tumorigenesis
Hu, Y., Zeng, T., Zheng, X. W., Hu, Q.-H., Li, Y., Tan, X., Yue, H., Wang, W., Tan, H., & Zou, J. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2019.12.030 · Cited by 28
Naikawadi, R. P., Green, G., Jones, K. D., Achtar‐Zadeh, N., Mieleszko, J. E., Arnould, I. S., Kukreja, J., Greenland, J. R., & Wolters, P. J. (2020) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2019-0374oc · Cited by 28
“Consistent with these reports, we found gH2AX-positive DNA damage foci and positive staining for cellular senescence markers in tamoxifen-treated SCGB1a1-cre TRF1 transgenic mice, which could amplify local inflammatory responses (37).”
ResultRe, A., Corà, D., Puliti, A., Caselle, M., & Sbrana, I. (2006) · BMC Bioinformatics · doi:10.1186/1471-2105-7-413 · Cited by 28
Estradiol regulates MICA expression in human endometrial cells
Basu, S., Pioli, P. A., Conejo-Garcia, J. R., Wira, C. R., & Sentman, C. L. (2008) · Clinical Immunology · doi:10.1016/j.clim.2008.07.005 · Cited by 28
“NKG2D ligands share the characteristic that protein expression on the cell surface is almost undetectable in normal tissues, but expression can be induced by transformation, infection, or cellular stress, such as DNA damage [18,19].”
BackgroundOverexpression of the Transcription Factor Sp1 Activates the OAS-RNAse L-RIG-I Pathway
Dupuis-Maurin, V., Brinza, L., Baguet, J., Plantamura, É., Schicklin, S., Chambion, S., Macari, C., Tomkowiak, M., Deniaud, E., Leverrier, Y., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0118551 · Cited by 29
“We looked at the expression of the NKG2D ligand Rae as a marker of DNA damage response [34], but no up-regulation was Activation of the OAS-RNAse L-RIG-I Pathway by Sp1”
BackgroundChen, D., Hammer, J., Lindquist, D., Idahl, A., & Gyllensten, U. B. (2014) · Cancer Medicine · doi:10.1002/cam4.183 · Cited by 28
“But it is upregulated or expressed de novo in stressed conditions, such as during viral and bacterial infections [20, 24, 25], heat shock [22], DNA damage response [26], oncogenic transformation [18, 19], and in autoimmune conditions [27].”
BackgroundO’Driscoll, M. (2008) · DNA repair · doi:10.1016/j.dnarep.2008.02.010 · Cited by 29
Role of MICA antibodies in solid organ transplantation
Luo, L., Li, Z., Wu, W., Luo, G., Xu, C. L., Sun, Z., & Mei, H. (2013) · Clinical Transplantation · doi:10.1111/ctr.12295 · Cited by 28
Immune Microenvironment in Colorectal Cancer: A New Hallmark to Change Old Paradigms
de la Cruz‐Merino, L., Henao, F., Baz, D. V., Fernández, E. N., Zoilo, J. J. R., de Villena, M. C. M., & Pulido, E. G. (2011) · Clinical and Developmental Immunology · doi:10.1155/2011/174149 · Cited by 29
Unscrambling the role of human parvovirus B19 signaling in systemic autoimmunity
Tsay, G. J., & Zouali, M. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.04.023 · Cited by 28
Pedde, A., Kim, H., Donakonda, S., Baumann, T., Bayerl, F., Meiser, P., Hirschberger, A., Klement, C., Grassmann, S. A., Öllinger, R., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114855 · Cited by 27
Yet another role for natural killer cells: Cytotoxicity in immune regulation and viral persistence
Biron, C. A. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1120528109 · Cited by 27
“The ligands for this receptor are stress molecules induced under conditions of cell damage or viral infection (12), and activated T cells can express NKG2D ligands (13, 14).”
BackgroundProspects for NK Cell Therapy of Sarcoma
Lachota, M., Vincenti, M., Winiarska, M., Boye, K., Zagożdżon, R., & Malmberg, K. (2020) · Cancers · doi:10.3390/cancers12123719 · Cited by 29
“, RT, through activation of ATM and ATR pathways, consecutively alerting the immune system about potentially dangerous transforming cells [201].”
BackgroundDifferential p53-Mediated Cellular Responses to DNA-Damaging Therapeutic Agents
Carlsen, L., & El‐Deiry, W. S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111828 · Cited by 32
“Additionally, DNA-damaging agents [85] or p53 activation by other means [86–88] can upregulate the NK cell ligand ULBP2 to stimulate NK cell anti-tumor activity, however comparison across drugs has not been investigated.”
BackgroundA GATA4-regulated secretory program suppresses tumors through recruitment of cytotoxic CD8 T cells
Patel, R. S., Romero, R., Watson, E. V., Liang, A. C. T., Burger, M. L., Westcott, P. M. K., Mercer, K. L., Bronson, R. T., Wooten, E. C., Bhutkar, A. J., et al. (2022) · Nature Communications · doi:10.1038/s41467-021-27731-5 · Cited by 27
Zhang, Y., Liang, K., Zhou, X., Zhang, X., Xu, H. J., Dai, H., Song, X., Yang, X., Liu, B., Shi, T., et al. (2023) · Cancer Science · doi:10.1111/cas.15828 · Cited by 27
Moutafi, M. K., Koliou, G.-A., Papaxoinis, G., Economopoulou, P., Kotsantis, I., Gkotzamanidou, M. A., Anastasiou, Μ., Pectasides, D. G., Kyrodimos, E., Delides, A., et al. (2023) · Cancer Research Communications · doi:10.1158/2767-9764.crc-23-0051 · Cited by 30
Unlocking antitumor immunity with adenosine receptor blockers
Remley, V. A., Linden, J. M., Bauer, T. W., & Dimastromatteo, J. (2023) · Cancer Drug Resistance · doi:10.20517/cdr.2023.63 · Cited by 32
Huang, X., Huang, G., Song, H., & Chen, L. (2010) · International Journal of Cancer · doi:10.1002/ijc.25702 · Cited by 27
“DDP can up-regulate the expression of NKG2D ligand (NKG2DL) on tumor cells, thus sensitizing tumor cell to lysis of NKG2D-expressing lymphocytes.(20) DDP may also increase tumor cell expression of Fas, thereby increasing their vulnerability to Fas ligand (FasL)-positive immune effectors.”
BackgroundATM-Mediated DNA Damage Signals Mediate Immune Escape through Integrin-αvβ3–Dependent Mechanisms
Jinushi, M., Chiba, S., Baghdadi, M., Kinoshita, I., Dosaka‐Akita, H., Ito, K., Yoshiyama, H., Yagita∥, H., Uede, T., & Takaoka, A. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2028 · Cited by 29
“stress-related molecules such as NKG2D ligands (31).”
Desimio, M. G., Giuliani, E., & Doria, M. (2017) · Virology · doi:10.1016/j.virol.2017.06.033 · Cited by 29
“The expression of NKG2DLs can be induced by the DDR pathway, specifically via activation of the DNA damage sensor kinases ATM (ataxia telangiectasia-mutated) and ATR (ATM and Rad3-related) (Gasser et al., 2005).”
BackgroundMcCarthy, M. T., Lin, D., Soga, T., Adam, J., & O’Callaghan, C. A. (2019) · European Journal of Immunology · doi:10.1002/eji.201847948 · Cited by 27
Lifetime prevalence of cervical neoplasia in addicted and medical patients
Reece, A. S. (2007) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/j.1479-828x.2007.00769.x · Cited by 27
Yokoyama, W. M., & Riley, J. K. (2008) · Reproductive BioMedicine Online · doi:10.1016/s1472-6483(10)60573-1 · Cited by 30
“In mice, TLR signalling and DNA-damaging agents can induce NKG2D ligand expression (Hamerman et al., 2004; Gasser et al., 2005).”
BackgroundRoles of Vpr and Vpx in modulating the virus-host cell relationship
Planelles, V., & Barker, E. (2010) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2010.05.002 · Cited by 26
“Activation of the DNA damage pathway proteins ATR and ATM, after cells were exposed to genotoxic stress, resulted in the expression of ligands for the NK cell activation receptor, natural killer group 2, member D (NKG2D) (Gasser et al., 2005; Guerra et al., 2008).”
BackgroundResultInfluentialNatural killer cells and acute myeloid leukemia: promises and challenges
Rahmani, S., Yazdanpanah, N., & Rezaei, N. (2022) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-022-03217-1 · Cited by 28
“Anti-tumor activity of NK cells can be amplified through upregulation of activating receptors, which results in increasing sensitivity to tumor activating ligands [141, 142].”
BackgroundRodríguez-Agustín, A., Casanova, V., Grau-Expósito, J., Sánchez‐Palomino, S., Alcamí, J., & Climent, N. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15030917 · Cited by 28
“first reported that NKG2D ligands ULBP1, ULBP2 and ULBP3 were upregulated in human fibroblasts after ionizing radiation or inhibitors of DNA replication, stimuli that activate the ATM/ATR DNA damage response and are now known to induce cellular senescence [135].”
BackgroundLocal γδ T cells: translating promise to practice in cancer immunotherapy
Zlatareva, I., & Wu, Y. (2023) · British Journal of Cancer · doi:10.1038/s41416-023-02303-0 · Cited by 27
“Whilst it may hinder antigen-specific αβ T cell immunosurveillance, genomic instability also drives the expression of immunological stress ligands on cancer cells such as the MIC/ULBP families in humans and the RAE-1/H60/MULT1 families in mice [56, 57].”
BackgroundThe DNA damage response induces antigen presenting cell‐like functions in fibroblasts
Tang, M. L. F., Khan, M., Croxford, J. L., Tan, K. W., Angeli, V., & Gasser, S. (2013) · European Journal of Immunology · doi:10.1002/eji.201343781 · Cited by 28
Self-citationFortenbery, N. R., Paraiso, K. H. T., Taniguchi, M., Brooks, C. G., Ibrahim, L., & Kerr, W. G. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0901862 · Cited by 27
“These receptors enable responses to viral infections, tumor cells, allogeneic grafts and damaged cells (1, 2).”
BackgroundNew twist on the regulation of NKG2D ligand expression
Cerwenka, A. (2009) · The Journal of Experimental Medicine · doi:10.1084/jem.20090225 · Cited by 26
Cho, H.-M., Rosenblatt, J. D., Tolba, K. A., Shin, S. J., Shin, D. S., Calfa, C., Zhang, Y., & Shin, S.-U. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1047 · Cited by 27
Natural killer cells involved in tumour immune escape of hepatocellular carcinomar
Chen, H., Jiang, Y., Wang, Z., & Wang, H. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.04.057 · Cited by 29
Sinkovics, J., & Horvath, J. C. (2006) · International Journal of Oncology · doi:10.3892/ijo.29.4.765 · Cited by 28
“While these NK and immune T cells kill stressed tumor cells, this type of lymphocyte-mediated cytotoxicity is counteracted by soluble MICA and transforming growth factor-ß released from the cell or by IFN-Á which downregulates NKG2D receptor expression in NK cells (33,34).”
BackgroundTracing back primed resistance in cancer via sister cells
Dai, J., Zheng, S., Falco, M. M., Bao, J., Eriksson, J., Pikkusaari, S., Forstén, S., Jiang, J., Wang, W., Gao, L., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-45478-7 · Cited by 26
“DNA damage is known to induce NK-mediated cell killing 48 and aneuploidy activates NK clearance of non-transformed senescent cells via NF-κ B signaling 49 .”
BackgroundTargeting NKG2D in tumor surveillance
Hayakawa, Y. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2012.681378 · Cited by 26
“Direct evidence for a role of DNA damage response in NKG2D ligand expression was provided by the finding that DNA damaging agents or DNA replication inhibitors, but not other common forms of cellular stress, induce expression of cell surface NKG2D ligand in an ATM- or ATR-dependent mechanism [13,64].”
BackgroundIn Vivo Monitoring of Natural Killer Cell Trafficking during Tumor Immunotherapy
Maria, N. S. S., Barnes, S. R., & Jacobs, R. E. (2014) · Magnetic Resonance Insights · doi:10.4137/mri.s13145 · Cited by 25
Hadwiger, L. A., & Tanaka, K. (2017) · Frontiers in Plant Science · doi:10.3389/fpls.2017.00446 · Cited by 25
“Interestingly, the abundance of double strand breaks is reduced by plant defense responses, suggesting that the mechanisms for activating DNA repair processes may share some similarity with the induction of PR genes (Gasser et al., 2005; Yan et al., 2013).”
BackgroundImmunotherapy for Hepatocellular Carcinoma: New Prospects for the Cancer Therapy
Fasano, R., Shadbad, M. A., Brunetti, O., Argentiero, A., Calabrese, A., Nardulli, P., Calbi, R., Baradaran, B., & Silvestris, N. (2021) · Life · doi:10.3390/life11121355 · Cited by 25
“In the “altered self-response” mechanism, NK cells detect the high expression of cell stress ligands [66,67].”
BackgroundThe Unfolded Protein Response at the Tumor-Immune Interface
Zanetti, M., Su, X., Dosset, M., & Carter, H. K. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.823157 · Cited by 27
“Genotoxic stress signals activate NK cells via upregulation of NKG2D ligands in the mouse (101, 102) and in humans (103).”
Backgroundvan Luijk, I. F., Smith, S. M., Ojeda, M. C. M., Oei, A. L., Kenter, G. G., & Jordanova, E. S. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11092277 · Cited by 26
“One of the proposed mechanisms for this phenomenon is the induction of radiotherapy-mediated immunogenic cell death (ICD) [17], which increases antigen presentation by APCs, increased HLA-I on irradiated cells and NKG2D receptor ligands [17,96,97].”
BackgroundAlkhayer, R., Ponath, V., Frech, M., Adhikary, T., Graumann, J., Neubauer, A., & von Strandmann, E. P. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01118-z · Cited by 25
“In addition, KLF4 is essential for the cellular response to γ-irradiation-induced DNA damage [22], a process also known to induce NKG2D-L expression in mice [23].”
BackgroundGenetic Variation in DNA Repair Pathways and Risk of Non-Hodgkin's Lymphoma
Rendleman, J., Antipin, Y., Reva, B. A., Adaniel, C., Przybylo, J. A., Dutra-Clarke, A. V. C., Hansen, N. A. L., Heguy, A., Huberman, K. H., Borsu, L. A., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101685 · Cited by 25
“B-cell maturation in germinal centers) [58,70], suggesting that detailed exploration of such interactions will be important.”
BackgroundTomihara, K., Fuse, H., Heshiki, W., Takei, R., Zhang, B., Arai, N., Nakamori, K., & Noguchi, M. (2014) · Oral Oncology · doi:10.1016/j.oraloncology.2014.01.013 · Cited by 28
“We next addressed the question of whether GEM could modulate the phenotypes of cancer cells, because some chemotherapeutic agents have been shown to induce increased expressions of several surface molecules on cancer cells, including immune adhesion molecules, which resulted in enhanced cancer-cell immunogenicity [36–…”
BackgroundCharacterizing the anti-tumor function of adoptively transferred NK cells in vivo
Pegram, H. J., Haynes, N. M., Smyth, M. J., Kershaw, M. H., & Darcy, P. K. (2010) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-010-0848-7 · Cited by 25
Greene, T. T., Tokuyama, M., Knudsen, G. M., Kunz, M., Lin, J., Greninger, A. L., DeFilippis, V. R., DeRisi, J. L., Raulet, D. H., & Coscoy, L. (2016) · eLife · doi:10.7554/elife.14749 · Cited by 25
“In this regard, several stimuli leading to ligand expression have been identified, these include: DNA damage (Gasser et al., 2005), hyper-proliferation (though the transcription factor E2F) (Jung et al.”
BackgroundMethodSelf-citationInsights Into Cetacean Immunology: Do Ecological and Biological Factors Make the Difference?
Marsili, L., Guardo, G. D., Mazzariol, S., & Casini, S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01219 · Cited by 25
Singh, S., & Banerjee, S. (2020) · Scientific Reports · doi:10.1038/s41598-020-62081-0 · Cited by 25
DNA Damage and Tumor Surveillance: One Trigger for Two Pathways
Höglund, P. (2006) · Science s STKE · doi:10.1126/stke.3172006pe2 · Cited by 27
“show that ligands for the receptor NKG2D, which is expressed by natural killer cells of the innate immune system and also by some T cells, are up-regulated by the same kind of DNA damage response (3).”
BackgroundImmunological signatures from irradiated cancer-associated fibroblasts
Berzaghi, R., Gundersen, K., Pedersen, B. D., Utne, A., Yang, N., Hellevik, T., & Martínez-Zubiaurre, I. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1433237 · Cited by 27
Histone deacetylases: A novel class of therapeutic targets for pancreatic cancer
Xiang, X.-S., Li, P., Wang, W., & Liu, L. (2022) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2022.188676 · Cited by 26
Chitadze, G., & Kabelitz, D. (2022) · Scandinavian Journal of Immunology · doi:10.1111/sji.13201 · Cited by 25
Impaired intratumoral natural killer cell function in head and neck carcinoma
Mele, D., Pessino, G., Trisolini, G., Luchena, A., Benazzo, M., Morbini, P., Mantovani, S., Oliviero, B., Mondelli, M. U., & Varchetta, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.997806 · Cited by 24
“NKG2D receptors recognize several molecules, such as MHC class I chain-related molecules (MIC)A/B and the cytomegalovirus UL-16 protein (ULBP1-6), the expression of which is induced on the cell surface as a result of cellular stress conditions (25).”
BackgroundThe DNA damage response pathway regulates the expression of the immune checkpoint CD47
Ghantous, L., Volman, Y., Hefez, R., Wald, O., Stern, E., Friehmann, T., Chajut, A., Bremer, E., Elhalel, M. D., & Rachmilewitz, J. (2023) · Communications Biology · doi:10.1038/s42003-023-04615-6 · Cited by 27
Himmelreich, H., Mathys-Schneeberger, A., Wodnar‐Filipowicz, A., & Kalberer, C. P. (2011) · Human Immunology · doi:10.1016/j.humimm.2011.03.005 · Cited by 25
Emerging Immunotherapy Strategies in Breast Cancer
Page, D. B., Naidoo, J., & McArthur, H. L. (2014) · Immunotherapy · doi:10.2217/imt.13.166 · Cited by 25
Davis, Z., Sowrirajan, B., Cogswell, A. C., Ward, J. P., Planelles, V., & Barker, E. (2016) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2015.0375 · Cited by 24
Hu, J., Bernatchez, C., Zhang, L., Xia, X., Kleinerman, E. S., Hung, M., Hwu, P., & Li, S. (2017) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-16-0234 · Cited by 24
“Various chemotherapeutic agents have been found to induce NKG2D ligands on tumor cells in vitro (17).”
Convergent Evolution by Cancer and Viruses in Evading the NKG2D Immune Response
Baugh, R. T., Khalique, H., & Seymour, L. W. (2020) · Cancers · doi:10.3390/cancers12123827 · Cited by 29
“This increased NKG2DL expression was found to occur in an ataxia telangiectasia, mutated- (ATM), ATM- and Rad3-related- (ATR) and checkpoint kinase (Chk) 1-dependent manner, sensitising cells to lysis by NK cells [32].”
BackgroundInduction of T Cell Senescence by Cytokine Induced Bystander Activation
Abbas, A. A., & Akbar, A. N. (2021) · Frontiers in Aging · doi:10.3389/fragi.2021.714239 · Cited by 24
“Senescent cells become immunogenic by expressing stimulatory ligands like MICA/B that bind to NKG2D and activate NK cells killing (Gasser et al., 2005; Krizhanovsky et al., 2008; Sagiv et al., 2016).”
BackgroundPRL-3 Mediates the Protein Maturation of ULBP2 by Regulating the Tyrosine Phosphorylation of HSP60
Leung, W., Vong, Q. P., Lin, W., Bouck, D. C., Wendt, S., Sullivan, E., Li, Y., Bari, R., Chen, T., & Leung, W. H. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1400817 · Cited by 25
Lee, Y. S., Heo, W., Nam, J., Jeung, Y. H., & Bae, J. (2018) · Journal of Radiation Research · doi:10.1093/jrr/rry005 · Cited by 24
A Concise Review of the Role of the NKG2D Receptor and Its Ligands in Cancer
Boneva, E., Shivarov, V. S., & Ivanova, M. (2025) · Immuno · doi:10.3390/immuno5010009 · Cited by 24
“This leads to the consistent expression of NKG2DLs in precancerous lesions, early cancer stages, and advanced tumors [100].”
Innate immunity: Looking beyond T-cells in radiation and immunotherapy combinations
McMahon, R. A., D’Souza, C., Neeson, P. J., & Siva, S. (2023) · Neoplasia · doi:10.1016/j.neo.2023.100940 · Cited by 24
Killing the Killer: Natural Killer Cells to Treat Ewing's Sarcoma
Ahn, Y., Weigel, B. J., & Verneris, M. R. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1368 · Cited by 23
“These results are likely explained by the findings of Gasser, who showed the relationship between irradiation, genotoxic stress, cell cycle arrest, and the upregulation of NKG2D ligands (3).”
ResultNatural Killer Group 2, Member D/NKG2D Ligands in Hematopoietic Cell Transplantation
Carapito, R., Aouadi, I., Ilias, W., & Bahram, S. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00368 · Cited by 23
“Data from both mice and human indicate that NKG2DL are induced by DNA damaging agents such as 5-aza-2′-deoxycytidine (decitabine), a conditioning treatment used in myelodysplastic syndromes (22, 23, 58).”
BackgroundRecognition by natural killer cells of N6‐isopentenyladenosine‐treated human glioma cell lines
Ciaglia, E., Laezza, C., Abate, M., Pisanti, S., Ranieri, R., D’Alessandro, A., Picardi, P., Gazzerro, P., & Bifulco, M. (2017) · International Journal of Cancer · doi:10.1002/ijc.31036 · Cited by 23
“Recently, it has been shown that activation of the ATM/ATR protein kinases by DNA Damage can result in upregulation of certain NKG2D ligands(9) in both p53-positive and p53-null cells in an ATM- and ATR-dependent fashion.(44) Interestingly in HUVEC in vitro cell model of angiogenesis, we previously experienced cell cy…”
BackgroundIL-10 in cancer: Just a classical immunosuppressive factor or also an immunostimulating one?
Berti, F. C. B., & de Oliveira, K. B. (2018) · AIMS Allergy and Immunology · doi:10.3934/allergy.2018.2.88 · Cited by 25
“…several signaling pathways, as the 70 kilodalton heat shock protein (HSP70) mediated cellular stress [11] and the ataxia telangiectasia mutated/ataxia telangiectasia and Rad3-related protein (ATM/ATR) mediated DNA damage pathways [12], triggering effector functions of NK cells against tumor cells.”
APLP2 regulates the expression of MHC class I molecules on irradiated Ewing’s sarcoma cells
Peters, H. L., Yan, Y., & Solheim, J. C. (2013) · OncoImmunology · doi:10.4161/onci.26293 · Cited by 26
“Other studies have found that irradiation increases the expression of MHC class I molecules, as well as other immune receptors, on the surface of cancer cells in situ or in culture.(33,37) Studies based on melanoma models have demonstrated that even a partial reduction of surface-exposed MHC class I molecules can decr…”
Identification of the rat NKG2D ligands, RAE1L and RRLT, and their role in allograft rejection
Zhuo, M., Fujiki, M., Wang, M., Piard, K., Wai, L., Wei, L., Martinez, O. M., & Krams, S. M. (2010) · European Journal of Immunology · doi:10.1002/eji.200939779 · Cited by 23
“DNA-damaging reagents have been shown to induce the expression of NKG2DL [20].”
BackgroundTang, H., Sampath, P., Yan, X., & Thorne, S. H. (2013) · Gene Therapy · doi:10.1038/gt.2012.96 · Cited by 24
A Truncated Human NKG2D Splice Isoform Negatively Regulates NKG2D-Mediated Function
Karimi, M. A., Aguilar, O. A., Zou, B.-X., Bachmann, M. H., Carlyle, J. R., Baldwin, C. L., & Kambayashi, T. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400920 · Cited by 22
A Proposed Link Between Acute Thymic Involution and Late Adverse Effects of Chemotherapy
Lagou, M. K., Anastasiadou, D. P., & Karagiannis, G. S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.933547 · Cited by 22
Klingel, K., Fabritius, C., Sauter, M., Göldner, K., Stauch, D., Kandolf, R., Ettischer, N., Gahlen, S., Schönberger, T., Ebner, S., et al. (2014) · The Journal of Pathology · doi:10.1002/path.4369 · Cited by 22
Modulation of inflammation and disease tolerance by DNA damage response pathways
Neves‐Costa, A., & Moita, L. F. (2016) · FEBS Journal · doi:10.1111/febs.13910 · Cited by 27
“The retinoic acid early transcript, RAE1, is an NKG2DL induced by DNA damage (74, 76).”
BackgroundInfluentialMachuldová, A., Holubová, M., Caputo, V. S., Čedíková, M., Jindra, P., Houdová, L., & Pitule, P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.651751 · Cited by 22
“Besides of these stimuli, these ligands can be upregulated by standard cell-stress conditions including heat shock (28), oxidative stress (29), and ionizing radiation (28, 30).”
BackgroundEffects of Chronic Low-Dose Internal Radiation on Immune-Stimulatory Responses in Mice
Khan, A. U. H., Blimkie, M., Yang, D., Serran, M., Pack, T., Wu, J., Kang, J.-Y., Laakso, H., Lee, S.-H., & Le, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147303 · Cited by 22
“Several studies have shown that various types of stimuli, including radiation exposure, can upregulate a variety of NKG2D ligands on the surface of stressed cells [65,70,72,94], and the expression of these stress molecules can consequently regulate the NKG2D expression levels on NK cells [95].”
BackgroundKunisky, A. K., Anyaeche, V. I., Herron, R. S., Park, C. Y., & Hwang, H. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109815 · Cited by 23
“For example, a concurrent blockage of PD-L1 chosen because they have different anatomical origins, and we previously characterized their dependence to different mRNA 3 ′ end processing factors in APA regulation (Hwang et al., 2016).”
InfluentialLiu, M., Du, M., Yu, J., Qian, Z., Gao, Y., Pan, W., Zhao, X., Wang, M., Li, H., Zheng, J., et al. (2022) · OncoImmunology · doi:10.1080/2162402x.2021.2016158 · Cited by 22
“Furthermore, p53 was indispensable for the induction of NKG2D ligands by DNA-damaging agents.(27) In addition, RAS activation is also associated with the induction of the NKG2D ligands ULBP1–3 in human cells.”
BackgroundDoloff, J. C., & Waxman, D. J. (2015) · BMC Cancer · doi:10.1186/s12885-015-1358-y · Cited by 23
“Macrophage marker CD68, platelet marker PF4, dendritic cell markers CD74, implicated in DC migration [75], and CD209 (DC-SIGN), important for antigen presentation, were also increased, as were NK cell markers NKp46 (Ncr1) and NK1.”
BackgroundLeung, W. H., Neale, G. A. M., Behm, F. G., Iyengar, R. V., Finkelstein, D., Kastan, M. B., & Pui, C. (2010) · Cancer Epidemiology · doi:10.1016/j.canep.2010.03.008 · Cited by 23
“DNA damage responses may also alert the immune system by inducing cell surface expression of ligands for activating immune receptors of innate immunity, such as NKG2D which is expressed by natural killer cells, as well as triggering the development of adaptive immunity [45,46].”
BackgroundA short half‐life of ULBP1 at the cell surface due to internalization and proteosomal degradation
Fernández‐Messina, L., Reyburn, H. T., & Valés‐Gómez, M. (2016) · Immunology and Cell Biology · doi:10.1038/icb.2016.2 · Cited by 22
The context-dependent effect of cellular senescence: From embryogenesis and wound healing to aging
Lavarti, R., Alvarez-Diaz, T., Marti, K., Kar, P., & Raju, R. P. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102760 · Cited by 21
Synergistic Anticancer Effects of Pam3CSK4 and Ara-C on B-Cell Lymphoma Cells
Lee, S.-K., Chwee, J. Y., Ma, C. A. P., Bert, N. L., Huang, C. W., & Gasser, S. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2522 · Cited by 22
“Transduction of cells was performed as previously described (17).”
MethodSelf-citationDendritic cell-based cancer vaccination:quo vadis?
Dauer, M., Schnurr, M., & Eigler, A. (2008) · Expert Review of Vaccines · doi:10.1586/14760584.7.7.1041 · Cited by 24
Integrating conventional and antibody-based targeted anticancer treatment into immunotherapy
Xu, M. M., Pu, Y., Weichselbaum, R. R., & Fu, Y. (2016) · Oncogene · doi:10.1038/onc.2016.231 · Cited by 21
“NKG2D ligands, an activating receptor for NK cells are demonstrated to be up-regulated by radiotherapy therefore rendering radiated-tumor cells more susceptible to NK-cell mediated cytolysis(49).”
BackgroundTumor-derived CSF-1 induces the NKG2D ligand RAE-1δ on tumor-infiltrating macrophages
Thompson, T. W., Jackson, B. T., Li, P. J., Wang, J., Kim, A. B., Huang, K. T. H., Zhang, L., & Raulet, D. H. (2018) · eLife · doi:10.7554/elife.32919 · Cited by 21
“A prominent example is the induction of NKG2D ligands in mouse and human cells as a result of an activated DNA damage response (Gasser et al., 2005).”
BackgroundSelf-citationSmalley, M., Natarajan, S. K., Mondal, J., Best, D., Goldman, D. A., Shanthappa, B., Pellowe, M., Dash, C. P., Saha, T., Khiste, S., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-4036 · Cited by 23
Wu, X., Sharma, A., Oldenburg, J., Weiher, H., Essler, M., Skowasch, D., & Schmidt‐Wolf, I. G. H. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.731767 · Cited by 21
Type 1 interferons contribute to the clearance of senescent cell
Katlinskaya, Y. V., Carbone, C. J., Yu, Q., & Fuchs, S. Y. (2015) · Cancer Biology & Therapy · doi:10.1080/15384047.2015.1056419 · Cited by 25
“These ligands were shown to enable the detection of senescent cells by NK cells for subsequent cytotoxic elimination.(10,11,13) Accordingly, neutralization of IFNb in vitro or knockdown of IFNAR1 in vivo in target senescent cells attenuated clearance of these cells (Figs.”
BackgroundResultInfluentialChen, D., & Gyllensten, U. B. (2014) · Cancer Medicine · doi:10.1002/cam4.192 · Cited by 21
“Normally, MICA is constitutively expressed in low levels on epithelial cells in the gut and thymus, endothelial cells, fibroblasts, and monocytes [30–32], but is upregulated or expressed de novo in stressed conditions, such as during viral and bacterial infections [29, 33, 34], heat shock [22], DNA damage response [35…”
BackgroundAdoptive Cellular Therapy (ACT) for Cancer Treatment
Yang, F., Jin, H., Wang, J., Sun, Q., Yan, C., Wei, F., & Ren, X. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-94-017-7555-7_4 · Cited by 25
Multhoff, G. (2009) · International Journal of Hyperthermia · doi:10.1080/02656730902835672 · Cited by 21
“The role of standard radiochemotherapy [29] and hyperthermia as potential tools to enhance the expression of danger signals on the cell surface of tumor cells is presently under investigation [30].”
BackgroundProteome-wide Mendelian randomization identifies causal plasma proteins in lung cancer
Li, H., Du, S., Dai, J., Jiang, Y., Li, Z., Fan, Q., Zhang, Y., You, D., Zhang, R., Zhao, Y., et al. (2024) · iScience · doi:10.1016/j.isci.2024.108985 · Cited by 22
Effector Functions of Natural Killer Cell Subsets in the Control of Hematological Malignancies
Gismondi, A., Stabile, H., Nisti, P., & Santoni, A. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00567 · Cited by 20
Metadata
- Authors
- Gasser, S., Orsulic, S., Brown, E. J., & Raulet, D. H.
- Affiliations
- University of California, Berkeley (US)
- University of Pennsylvania (US)
- Corresponding author
- Raulet, David H.
- Venue
- Nature
- Published
- 2005-07-03
- Volume
- 436
- Issue
- 7054
- Pages
- 1186-1190
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC1352168
- OpenAlex
- W1969464492
- Cited by
- 1,308
- References
- 28
- Citations by year
- 2026: 23 · 2025: 39 · 2024: 26 · 2023: 51 · 2022: 57 · 2021: 60 · 2020: 72 · 2019: 62 · 2018: 62 · 2017: 64 · 2016: 63 · 2015: 71 · 2014: 85 · 2013: 74 · 2012: 68
- FWCI
- 28.11
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Prostate Cancer Foundation
- National Institutes of Health
- National Cancer Institute (R01CA093678)
- National Institute of Allergy and Infectious Diseases (R01AI039642)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Keywords
- NKG2D, NKG2D ligands, DNA damage response, innate immunity, ATM kinase, ATR kinase, Chk1, genotoxic stress, natural killer cells, CD8+ T cells, cancer cell lines, siRNA
- MeSH terms
- Checkpoint Kinase 1, Animals, Cell Transformation, Neoplastic, DNA Damage, DNA Replication, Fibroblasts, Humans, Immune System, Immunity, Innate, Kinetics, Ligands, Mice, Inbred C57BL, Phosphorylation, Protein Kinases, Receptors, Immunologic, Up-Regulation, Aphidicolin, Protein Serine-Threonine Kinases, Cell Cycle Proteins, Cell Line, Tumor, Mice, Receptors, Natural Killer Cell, NK Cell Lectin-Like Receptor Subfamily K, Ataxia Telangiectasia Mutated Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.